Singapore will include the Nuvaxovid Covid-19 vaccine by Novavax in the republic’s National Vaccination Programme for use in individuals aged 18 years and above, for both Covid-19 primary and booster vaccination.

According to the Singapore Multi-Ministry Taskforce (MTF) on Covid-19, it has accepted the recommendation of the Expert Committee on Covid-19 Vaccination for the inclusion of Nuvaxovid, a protein subunit vaccine, in the programme.

“This follows the...